Nakaba Murata

521 total citations
8 papers, 432 citations indexed

About

Nakaba Murata is a scholar working on Physiology, Pharmacology and Molecular Biology. According to data from OpenAlex, Nakaba Murata has authored 8 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in Nakaba Murata's work include Alzheimer's disease research and treatments (6 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Prion Diseases and Protein Misfolding (2 papers). Nakaba Murata is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Prion Diseases and Protein Misfolding (2 papers). Nakaba Murata collaborates with scholars based in Japan and Australia. Nakaba Murata's co-authors include Kazuma Murakami, Takahiko Shimizu, Kazuhiro Irie, Takuji Shirasawa, Noriaki Kinoshita, Yoshihiro Noda, Yusuke Ozawa, Hiroyuki Hatsuta, Shigeo Murayama and Takao Kaneko and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Alzheimer s Disease.

In The Last Decade

Nakaba Murata

8 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nakaba Murata Japan	6	248	137	109	83	46	8	432
Mari-Carmen Badía Spain	8	271 1.1×	181 1.3×	75 0.7×	68 0.8×	55 1.2×	8	476
Maria-Dolores Alonso Spain	7	252 1.0×	158 1.2×	71 0.7×	59 0.7×	51 1.1×	7	434
Sávio Monteiro dos Santos Brazil	9	188 0.8×	141 1.0×	57 0.5×	54 0.7×	56 1.2×	19	538
Grant Stuchbury Australia	10	254 1.0×	240 1.8×	131 1.2×	50 0.6×	91 2.0×	10	747
Marlene Kenklies Germany	3	183 0.7×	182 1.3×	101 0.9×	42 0.5×	50 1.1×	5	541
Phillip F. Giannopoulos United States	11	175 0.7×	131 1.0×	81 0.7×	30 0.4×	87 1.9×	12	380
Magisetty Obulesu India	10	310 1.3×	218 1.6×	149 1.4×	49 0.6×	95 2.1×	13	614
Mauro Baglioni Italy	9	279 1.1×	142 1.0×	65 0.6×	178 2.1×	73 1.6×	11	570
Robert A. Leedle United States	7	242 1.0×	148 1.1×	84 0.8×	60 0.7×	28 0.6×	11	450
Hebatalla I. Ahmed Egypt	13	88 0.4×	140 1.0×	101 0.9×	46 0.6×	45 1.0×	34	532

Countries citing papers authored by Nakaba Murata

Since Specialization

Citations

This map shows the geographic impact of Nakaba Murata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nakaba Murata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nakaba Murata more than expected).

Fields of papers citing papers by Nakaba Murata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nakaba Murata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nakaba Murata. The network helps show where Nakaba Murata may publish in the future.

Co-authorship network of co-authors of Nakaba Murata

This figure shows the co-authorship network connecting the top 25 collaborators of Nakaba Murata. A scholar is included among the top collaborators of Nakaba Murata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nakaba Murata. Nakaba Murata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Murakami, Kazuma, Nakaba Murata, Yusuke Ozawa, et al.. (2013). P2–418: Vitamin C and silymarin restores beta‐amyloid oligomerization and behavioral abnormality in Alzheimer's disease pathology. Alzheimer s & Dementia. 9(4S_Part_13). 3 indexed citations

Murakami, Kazuma, Nakaba Murata, Yoshihiro Noda, et al.. (2012). Stimulation of the Amyloidogenic Pathway by Cytoplasmic Superoxide Radicals in an Alzheimer's Disease Mouse Model. Bioscience Biotechnology and Biochemistry. 76(6). 1098–1103. 18 indexed citations

Murakami, Kazuma, Nakaba Murata, Yoshihiro Noda, et al.. (2011). SOD1 (Copper/Zinc Superoxide Dismutase) Deficiency Drives Amyloid β Protein Oligomerization and Memory Loss in Mouse Model of Alzheimer Disease. Journal of Biological Chemistry. 286(52). 44557–44568. 204 indexed citations

Murakami, Kazuma, Nakaba Murata, Yusuke Ozawa, et al.. (2011). Insulin receptor mutation results in insulin resistance and hyperinsulinemia but does not exacerbate Alzheimer’s-like phenotypes in mice. Biochemical and Biophysical Research Communications. 409(1). 34–39. 19 indexed citations

Irie, Kazuhiro, Kazuma Murakami, Yuichi Masuda, et al.. (2011). Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23. Rinsho Shinkeigaku. 51(11). 890–891. 1 indexed citations

Murakami, Kazuma, Nakaba Murata, Yusuke Ozawa, et al.. (2011). Vitamin C Restores Behavioral Deficits and Amyloid-β Oligomerization without Affecting Plaque Formation in a Mouse Model of Alzheimer's Disease. Journal of Alzheimer s Disease. 26(1). 7–18. 75 indexed citations

Murata, Nakaba, Kazuma Murakami, Yusuke Ozawa, et al.. (2010). Silymarin Attenuated the Amyloid β Plaque Burden and Improved Behavioral Abnormalities in an Alzheimer’s Disease Mouse Model. Bioscience Biotechnology and Biochemistry. 74(11). 2299–2306. 68 indexed citations

Murakami, Kazuma, Nakaba Murata, Yoshihiro Noda, et al.. (2010). Monoclonal Antibody Against the Turn of the 42-Residue Amyloid β-Protein at Positions 22 and 23. ACS Chemical Neuroscience. 1(11). 747–756. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact